During this webinar, our toxicology experts provide an informative and fascinating review of the ever-changing landscape of the illicit drug market. Labcorp’s R&D scientific director shares insights related to the history of designer drugs, new uses for age-old drugs and how Labcorp responds to evolving drug trends. Most importantly we discuss the relevance of these drug trends in routine clinical practice.

This webinar includes:

  • History of drug trends
  • Spotlight - Xylazine and other novel agents
  • Impact of evolving trends on your clinical practice
  • Q&A with the presenters


Hemamalini Ketha, PhD, NRCC, SC (ASCP), FAACC
Discipline Director, Clinical Toxicology

Gregory Clark Janis, MS 
R&D Technical Director, Director of Mass Spectrometry